Sharp Therapeutics

Sharp Therapeutics is a biotechnology company focused on developing small molecule drugs to treat genetic diseases by addressing their core cause. The company creates medications that can be taken as pills to restore the function of mutated proteins, thereby correcting the fundamental imbalance caused by loss of function mutations. Sharp Therapeutics serves patients suffering from genetic disorders, particularly those involving loss of function mutations and haploinsufficiency, which is when one copy of a gene is not sufficient to maintain normal function.

Operating in the biopharmaceutical market, Sharp Therapeutics employs a business model centered around research and development (R&D) of innovative therapies. The company generates revenue through the development and commercialization of its proprietary drugs, supported by investments from stakeholders who share its mission of transforming patient lives. The team comprises experienced scientists, clinicians, data scientists, and genetic disease experts dedicated to bringing effective therapies to patients.

Keywords: small molecule drugs, genetic diseases, protein function, biotechnology, biopharmaceutical, R&D, haploinsufficiency, innovative therapies, patient-focused, drug development.